2-Methoxyestradiol


2-Methoxyestradiol
Systematic (IUPAC) name
(8R,9S,13S,14S,17S)-2-methoxy- 13-methyl-6,7,8,9,11,12,14,15,16,17- decahydrocyclopenta[a]phenanthrene-3,17-diol
Identifiers
CAS number	362-07-2
ATC code	?
PubChem	66414
Chemical data
Formula	C₁₉H₂₆O₃
Mol. mass	302.408 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

2-Methoxyestradiol (2ME2) is a drug that prevents the formation of new blood vessels that tumors need in order to grow (angiogenesis). It is derived from estrogen, although it binds poorly to known estrogen receptors, and belongs to the family of drugs called angiogenesis inhibitors. It has undergone Phase 1 clinical trials against breast cancers. Preclinical models also suggest that 2ME2 could also be effective against inflammatory diseases such as rheumatoid arthritis. The CAS name for 2ME2 is (17 beta)-2-methoxyestra-1,3,5(10)-triene-3,17-diol. It also acts as a vasodilator.

External links

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

The original article is from Wikipedia. To view the original article please click here.
Creative Commons Licence

Custom Search